Zacks: Analysts Anticipate Walgreens Boots Alliance Inc (WBA) Will Announce Quarterly Sales of $33.56 Billion

Equities research analysts predict that Walgreens Boots Alliance Inc (NASDAQ:WBA) will report sales of $33.56 billion for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have issued estimates for Walgreens Boots Alliance’s earnings. The highest sales estimate is $34.86 billion and the lowest is $31.34 billion. Walgreens Boots Alliance reported sales of $30.12 billion during the same quarter last year, which would suggest a positive year over year growth rate of 11.4%. The firm is scheduled to announce its next earnings report on Thursday, July 5th.

According to Zacks, analysts expect that Walgreens Boots Alliance will report full-year sales of $130.67 billion for the current year, with estimates ranging from $124.02 billion to $133.29 billion. For the next year, analysts anticipate that the business will report sales of $137.87 billion per share, with estimates ranging from $127.51 billion to $141.63 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Walgreens Boots Alliance.

How to Become a New Pot Stock Millionaire

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.18. The business had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The firm’s revenue was up 12.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.36 EPS.

A number of brokerages have commented on WBA. BidaskClub lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, April 10th. Jefferies Group set a $85.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, April 3rd. Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 price objective (up from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday, January 10th. Barclays assumed coverage on Walgreens Boots Alliance in a research report on Thursday, March 8th. They set an “equal weight” rating and a $76.00 target price for the company. Finally, Bank of America assumed coverage on Walgreens Boots Alliance in a research report on Tuesday, February 27th. They set a “neutral” rating and a $76.00 target price for the company. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $83.20.

NASDAQ WBA traded down $1.36 on Monday, reaching $63.92. The stock had a trading volume of 5,919,509 shares, compared to its average volume of 6,108,190. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45. Walgreens Boots Alliance has a 1-year low of $61.74 and a 1-year high of $87.79. The firm has a market cap of $64,735.93, a price-to-earnings ratio of 12.53, a P/E/G ratio of 1.05 and a beta of 1.16.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Investors of record on Friday, May 18th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 2.50%. Walgreens Boots Alliance’s dividend payout ratio is currently 31.37%.

A number of institutional investors have recently bought and sold shares of the business. Parkside Investments LLC raised its position in Walgreens Boots Alliance by 3.0% in the fourth quarter. Parkside Investments LLC now owns 24,806 shares of the pharmacy operator’s stock valued at $1,801,000 after purchasing an additional 715 shares during the last quarter. BTIM Corp. raised its position in Walgreens Boots Alliance by 3.5% in the fourth quarter. BTIM Corp. now owns 21,457 shares of the pharmacy operator’s stock valued at $1,558,000 after purchasing an additional 725 shares during the last quarter. Eads & Heald Investment Counsel increased its stake in shares of Walgreens Boots Alliance by 3.6% in the fourth quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock valued at $1,543,000 after buying an additional 748 shares during the period. Iberiabank Corp increased its stake in shares of Walgreens Boots Alliance by 7.0% in the third quarter. Iberiabank Corp now owns 11,474 shares of the pharmacy operator’s stock valued at $886,000 after buying an additional 753 shares during the period. Finally, IFM Investors Pty Ltd increased its stake in shares of Walgreens Boots Alliance by 3.0% in the third quarter. IFM Investors Pty Ltd now owns 25,769 shares of the pharmacy operator’s stock valued at $1,990,000 after buying an additional 762 shares during the period. Hedge funds and other institutional investors own 60.90% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://weekherald.com/2018/04/21/zacks-analysts-anticipate-walgreens-boots-alliance-inc-wba-will-announce-quarterly-sales-of-33-56-billion.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply